
Insurance and indemnities
The Company maintains appropriate
insurance to cover Directors’ and Officers’
liability for itself and its subsidiaries.
In addition the Company indemnifies
each Director under a separate deed of
indemnity. The Company also indemnifies
each Director under its Articles of
Association. Such indemnities are
qualifying indemnities for the purposes
of, and permitted under, section 234
of the Act.
Directors’ interests
The number of ordinary shares in
which the Directors were beneficially
interested as at 31 December 2021 is
set out in the Directors’ Remuneration
Report on page 113. There were no
additional ordinary shares allotted to
the Directors In the period between 31
December 2021 and 8 March 2022.
There were no other changes during
that period to the number of ordinary
shares in which the Directors were
beneficially interested.
In line with the requirements of the Act,
each Director has notified the Company
of any situation in which he or she
has, or could have, a direct or indirect
interest that conflicts, or possibly
may conflict, with the interests of the
Company (a situational conflict). The
Board has formal procedures to deal
with Directors’ conflicts of interest.
None of the Directors has a material
interest in any significant contract
with the Company or any member of
its Group.
Results and dividends
The Group’s and the Company’s audited
financial statements for the year are set
out on pages 132 to 192.
The Directors do not recommend
payment of a final dividend for 2021
(2020: £nil).
Appointment and replacement
of Directors
The rules governing the appointment
and replacement of Directors are set
out in the Company’s Articles and are
governed by the Code, the Act and
related legislation. All Directors will
offer themselves for re-election to the
Company’s Board at the AGM.
Amendment of the Articles
The Company’s Articles of Association
may only be amended by a special
resolution at a general meeting of
shareholders. No amendments
are proposed to be made to the
existing Articles of Association at the
forthcoming AGM.
Authority to allot or purchase
the Company’s shares
The Articles permit the Directors to
issue or approve the purchase by the
Company of its own shares, subject to
obtaining shareholders’ prior approval.
The authority to issue or buy back
shares will expire at the 2022 AGM, and
it will be proposed at the meeting that
the Directors be granted new authorities
to issue and buy back shares. The
Directors currently have authority to
approve the Company’s purchase of
up to 35,330,154 of the Company’s
ordinary shares. However, the Company
did not repurchase any of its ordinary
shares during the year.
Share capital
The Company’s issued share capital
comprises ordinary shares of £0.001,
each of which are listed on the London
Stock Exchange. The issued share
capital of the Company as at 31
December 2021 comprises 356,619,718
ordinary shares of £0.001 each. Further
information regarding the Company’s
issued share capital can be found on
page 171 of the financial statements.
Details of the shares held by the Group’s
Employee Benefit Trusts are disclosed
in note 18 to the financial statements.
Rights attaching to shares
All shares have the same rights
(including voting and dividend rights
and rights on a return of capital) and
restrictions as set out in the Articles,
described below. Except in relation to
dividends and rights on a liquidation of
the Company, the shareholders have
no rights to share in the profits of the
Company. The Company’s shares are
not redeemable. However, following any
grant of authority from shareholders,
the Company may purchase or contract
to purchase any of the shares on or
off market, subject to the Act and the
requirements of the Listing Rules.
Voting rights
All members who hold ordinary shares
are entitled to attend and vote at the
AGM. On a show of hands at a general
meeting, every member present in
person shall have one vote and, on a
poll, every member present in person
or by proxy shall have one vote for
every share of which he or she is the
holder. No shareholder holds ordinary
shares carrying special rights relating
to the control of the Company and
the Directors are not aware of any
agreements between holders of the
Company’s shares that may result in
restrictions on voting rights.
Shares held by the Company’s
Employee Benefit Trusts rank pari
passu with the shares in issue and
have no special rights. Voting rights
and rights of acceptance of any offer
relating to shares held in trust rest with
the Trustees and are not exercisable
by employees, although the Trustees
will exercise such rights arising from
allocated shares in accordance with the
relevant participant’s directions.
Restrictions on transfer
ofsecurities
The Articles do not contain any
restrictions on the transfer of ordinary
shares in the Company other than the
usual restrictions applicable where any
amount is unpaid on a share. All issued
share capital of the Company at the
date of this report is fully paid. Certain
restrictions are also imposed by laws
and regulations (such as insider dealing
and market requirements relating to
closed periods) and requirements
of the Disclosure Guidance and
Transparency Rules, as well as the
Company’s own dealing codes, whereby
Directors, persons connected to the
Directors and certain employees of the
Company require approval to deal in the
Company’s securities.
Change of control
The details of the additional protections
that apply in the event of termination
of employment due to a takeover bid in
respect of certain of the CEO’s pre-IPO
awards are set out on page 102 under
“Legacy awards”. These additional
protections also apply to LTIP Awards
held by members of the GLT (but
excluding the Executive Directors). Save
in respect of these awards, there are no
agreements between the Company and
its Directors or employees providing
for compensation for loss of office
or employment (whether through
resignation, purported redundancy or
otherwise) because of a takeover bid.
Annual Report and Accounts 2021 121
STRATEGIC REPORT CORPORATE GOVERNANCE FINANCIAL STATEMENTS